Qiagen posts $548M in Q3 2026 net sales amid pending EQT deal
Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) released preliminary third-quarter 2026 financial results, reporting net sales of $548 million at both reported and constant exchange rates (CER).
Adjusted diluted earnings per share were $0.65, also $0.65 at CER.
The company plans to release full Q3 2026 results on November 4, 2026, at approximately 22:05 Frankfurt time / 16:05 New York time. Qiagen said it will not hold a conference call for the quarterly results.

Qiagen said it has suspended its full-year 2026 outlook due to a pending transaction with EQT Private Equity. The company did not provide additional details on the terms or timeline of the transaction in the preliminary results statement.

